Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 12.74 CNY -7.28% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Novogene Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Retained Earnings
ÂĄ866.5m
CAGR 3-Years
38%
CAGR 5-Years
37%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Retained Earnings
ÂĄ28.2B
CAGR 3-Years
41%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Retained Earnings
ÂĄ6.6B
CAGR 3-Years
39%
CAGR 5-Years
57%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Retained Earnings
ÂĄ19.1B
CAGR 3-Years
44%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Retained Earnings
ÂĄ9.2B
CAGR 3-Years
23%
CAGR 5-Years
45%
CAGR 10-Years
44%
W
WuXi XDC Cayman Inc
HKEX:2268
Retained Earnings
ÂĄ562.5m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Novogene Co Ltd
Glance View

Market Cap
5.3B CNY
Industry
Life Sciences Tools & Services

Novogene Co., Ltd. engages in the provision of genomic services and solutions. The company is headquartered in Beijing, Beijing and currently employs 2,284 full-time employees. The company went IPO on 2021-04-13. The firm mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. At the same time, based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The firm's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The firm conducts its businesses in domestic and overseas markets.

Intrinsic Value
22.68 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

What is Novogene Co Ltd's Retained Earnings?
Retained Earnings
866.5m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Retained Earnings amounts to 866.5m CNY.

What is Novogene Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
37%

Over the last year, the Retained Earnings growth was 23%. The average annual Retained Earnings growth rates for Novogene Co Ltd have been 38% over the past three years , 37% over the past five years .

Back to Top